Applied DNA Sciences, Inc. Appoints Bob Miglani as Chief of Business Development
May 05, 2016 at 10:04 am EDT
Share
Applied DNA Sciences Inc. has appointed Bob Miglani as Chief of Business Development. In his new full-time role, Mr. Miglani will be responsible for building the company's business within the FDA-regulated markets, including pharmaceuticals, foods, personal care and medical devices. He will also lead the team responsible for creating and driving commercial strategies within these large and important sectors. Mr. Miglani brings 23 years of deep industry experience from Pfizer Inc., where he served in a series of roles of increasing responsibility, most recently as Senior Director, External Medical Affairs.
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Companyâs proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Companyâs Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
APPLIED DNA SCIENCES, INC. 
